Breaking News
Get 45% Off 0
👀 What's the latest update on the stocks in my watchlist?
Ask WarrenAI
Close

2cureX AB (2CUREX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.97 -0.06    -2.96%
21:00:59 - Closed. Currency in SEK
Type:  Equity
Market:  Sweden
ISIN:  SE0010468124 
S/N:  25102916
  • Volume: 648,616
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 1.60 - 2.10
2cureX 1.97 -0.06 -2.96%

2cureX Company Profile

 
Explore the 2cureX company profile for core details about 2cureX, assess 2cureX company details, including a description of the company, key contact information, and insights into the top executives. Discover the company's operations and leadership to better understand its role in the industry.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

14

Equity Type

ORD

2cureX AB (publ) operates as a medtech company in Europe. The company’s principal product is IndiTreat, an IVD test, which helps to predict cancer patient’s response and resistance to different drugs and select the appropriate treatment. It is also conducting various clinical programs for IndiTreat for colorectal, ovarian, and pancreatic cancers. The company was incorporated in 2006 and is based in Copenhagen, Denmark.

Contact Information

Address Fruebjergvej 3
Copenhagen, 2100
Denmark
Phone 45 22 11 53 99
Fax -

Top Executives

Name Age Since Title
Dion Morton - - Member of Clinical Advisory Board
Andreas Block - - Member of Clinical Advisory Board
John Lindsay Marshall - 2021 Member of Clinical Advisory Board
Jesus Garcia-Foncillas - 2021 Member of Clinical Advisory Board
Patrick Markus Aisher 54 2024 Director
Grith Hagel 65 2024 Co-Founder, VP of Innovation & Director
Ole Thastrup 71 2006 Co-Founder & Chairman
Tonni Bülow-Nielsen - 2023 Director
Dan Honeywell - 2024 CEO & Director
Nathaniel Hutley - 2024 Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

2CUREX Comments

Write your thoughts about 2cureX AB
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email